SCHEMBL3203984

SCHEMBL3203984

CCn1ccc(Cl)c([N+](=O)[O-])c1=O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.44
NPC1 O15118 2/20 0.44
LMNA P02545 2/20 0.44
MAPT P10636 2/20 0.44
RAB9A P51151 2/20 0.44
NPSR1 Q6W5P4 2/20 0.44
TLR9 Q9NR96 2/20 0.44
HTT P42858 2/20 0.44
MITF O75030 1/20 0.44
AGTR1 P30556 1/20 0.44
SMN1; SMN2 Q16637 2/20 0.38
XBP1 P17861 1/20 0.38
PAX8 Q06710 1/20 0.38
TSHR P16473 2/20 0.36
GRIN2D O15399 2/20 0.35
GRIN3B O60391 2/20 0.35
GRIN1 Q05586 2/20 0.35
GRIN2A Q12879 2/20 0.35
GRIN2B Q13224 2/20 0.35
GRIN2C Q14957 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3207815 0.80 ALDH1A1 (0.38) ALDH1A1NPC1LMNAMAPTRAB9A
SCHEMBL3193163 0.80 GPR35 (0.40) ALDH1A1NPC1LMNAMAPTRAB9A
SCHEMBL3195504 0.80 HSPD1 (0.50) ALDH1A1NPC1LMNAMAPTRAB9A
SCHEMBL8030820 0.79 MITF (0.47) ALDH1A1LMNAMAPTRAB9AHTT
SCHEMBL7360418 0.78 MITF (0.46) ALDH1A1LMNAMAPTRAB9AHTT
SCHEMBL6286816 0.77 GAA (0.46) ALDH1A1NPC1LMNAMAPTRAB9A
SCHEMBL3190863 0.77 SMN1; SMN2 (0.47) ALDH1A1MAPTSMN1; SMN2CYP1A2MEN1
SCHEMBL7360414 0.77 MITF (0.45) ALDH1A1LMNAMAPTRAB9AHTT
SCHEMBL27041721 0.73 ALDH1A1 (0.38) ALDH1A1NPC1LMNAMAPTRAB9A
SCHEMBL12703143 0.72 GRM2 (0.46) ALDH1A1NPC1LMNAMAPTRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7678909-B1 2-[2-(3-Amino-cyclohexyl)-5-benzyl-4-oxo-4,5-dihydro-imidazo[4,5-c]pyridin-3-ylmethyl]-benzonitrile; type 2 diabetes mellitus, diabetic dislipidemia, impaired glucose tolerance; female infertility, osteoporosis, male contraception and neurological disorders TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2010-03-16 US disclosed
US-7169926-B1 Dipeptidyl peptidase inhibitors TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2007-01-30 US disclosed